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Abstract
Background: Infection with Plasmodium falciparum during pregnancy contributes substantially to the disease
burden in both mothers and offspring. Placental malaria may lead to intrauterine growth restriction or preterm
delivery resulting in low birth weight (LBW), which, in general, is associated with increased infant morbidity and
mortality. However, little is known about the possible direct impact of the specific disease processes occurring in
PM on longer term outcomes such as subsequent retarded growth development independent of LBW.
Methods: In an existing West-African cohort, 783 healthy infants with a birth weight of at least 2,000 g were
followed up during their first year of life. The aim of the study was to investigate if Plasmodium falciparum
infection of the placenta, assessed by placental histology, has an impact on several anthropometric parameters,
measured at birth and after three, six and 12 months using generalized estimating equations models adjusting for
moderate low birth weight.
Results: Independent of LBW, first to third born infants who were exposed to either past, chronic or acute
placental malaria during pregnancy had significantly lower weight-for-age (-0.43, 95% CI: -0.80;-0.07), weight-for-
length (-0.47, 95% CI: -0.84; -0.10) and BMI-for-age z-scores (-0.57, 95% CI: -0.84; -0.10) compared to infants born to
mothers who were not diagnosed with placental malaria (p = 0.019, 0.013, and 0.012, respectively). Interestingly,
the longitudinal data on histology-based diagnosis of PM also document a sharp decline of PM prevalence in the
Sukuta cohort from 16.5% in 2002 to 5.4% in 2004.
Conclusions: It was demonstrated that PM has a negative impact on the infant’s subsequent weight development
that is independent of LBW, suggesting that the longer term effects of PM have been underestimated, even in
areas where malaria transmission is declining.
Background
Despite the availability of appropriate tools to control
malaria and recently strengthened efforts to employ
them efficiently [1], the latest estimates still consider 3.3
billion people at risk of acquiring malaria each year. In
2006, 247 million malaria cases were reported, causing
almost one million deaths [2]. Approximately 50 million
pregnant women are at risk of malaria, more than 50%
of whom live in areas of sub-Saharan Africa with intense
transmission of Plasmodium falciparum[3]. In these
areas at least one in four pregnant women (all parities)
has evidence of malaria infection at delivery defined as
either peripheral malaria or placental malaria (PM) [4,5].
Where transmission is low, peripheral and placental
parasitaemia prevalence was estimated as 13.7% and
6.7%, respectively [6].
The deleterious effects of malaria in pregnancy on the
morbidity and mortality of fetuses and newborns are
well recognized. The impact of PM on the mother
depends on the level of acquired immunity and is more
severe in non-immune women. In highly endemic areas,
where women can be assumed to be partially immune,
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primigravidae. The main effects of malaria in preg-
nancy on birth outcomes are thought to be mediated
by maternal anaemia [7,8] and placental insufficiency
[9-13]. Both factors have been suggested to act
together to cause either intrauterine growth restriction
(IUGR) [14] or preterm delivery [15,16], leading to low
birth weight (LBW) [17-19]. A number of studies have
demonstrated a firm association between PM and
LBW [4,5,13,20], and in general, LBW itself is known
to be highly associated with infant morbidity and mor-
tality [21,22]. Likewise, in children born to mothers
with PM, the associated LBW has been suggested as a
major risk factor for neonatal and infant mortality
[23-25]. It has been estimated that PM causes 167,000-
967,000 cases of LBW in Africa, associated with
62,000-363,000 newborn deaths each year [4,26]. How-
ever, it has been emphasized that these infant deaths
are not due to the impact of LBW alone, but to the
general disease processes which have resulted in LBW
[27]. In addition, PM has been associated with a two-
fold increase in risk of stillbirth [28], and may put the
foetus at increased risk of congenital cytomogalovirus
infections [29]. While the immediate consequences of
PM and LBW on neonatal and infant morbidity and
mortality have been studied extensively, comparatively
little is known about the possible long-term impact of
PM on the subsequent development of the child. To
date only one study has shown that 12 month old
infants exposed to maternal malaria at delivery (pla-
cental or peripheral) were lighter and thinner than
children who were not exposed to PM [30], even after
controlling for low birth weight.
Since LBW in itself, regardless of the underlying pro-
cesses, has been associated with inhibited growth,
impaired cognitive development, and increased inci-
dence of chronic diseases later in life [31], it is difficult
to study potential direct effects of PM on the subse-
quent development of the child that are independent of
t h ee f f e c t sc a u s e db yt h ea s s o c i a t e dL B W .T h i ss t u d y
addressed whether PM has an additional or ‘indepen-
dent’ effect on growth development, apart from the
known effects of PM following the causal pathway
(exposure to PM → LBW → incomplete catch-up growth
[30] → growth retardation). The direct impact of PM on
the child’s subsequent growth development during the
first year of life was investigated by using data from an
ongoing Gambian cohort study, which was specifically
designed to enroll healthy babies, excluding those with a
birth weight below 2,000 g. This study design and sub-
sequent analysis adjusting for moderate low birth weight
(2,000 g - 2,499 g) offered the unique opportunity to
study the impact of PM independent of LBW or overt
co-morbidity.
Methods
Study participants and recruitment
Data were collected from children born between January
2002 and July 2005 as part of an ongoing open cohort
study at the maternity ward of the Health Centre in
Sukuta, a semi-urban Gambian village 30 km south of
the capital Banjul, where malaria transmission varies
considerably between season, with highest incidence
during the wet season and immediately afterwards
(’malaria season’: August - December). The main study,
as well as the analysis strategy of the data presented
here, was approved by the Joint Gambian Government/
MRC Ethics Committee. The newborns delivered at the
maternity ward were enrolled after informed consent of
the mother was obtained. The purpose of the main
cohort was to study immune responses of infants to vac-
cines and infections. Since overt morbidity, as well as
risk factors associated with LBW, are known to increase
susceptibility to infectious diseases and thus bias any
immunological responses [32-35] only healthy singleton
children were eligible for recruitment into the cohort.
Newborns below a birth weight of 2,000 g were
excluded from the study.
A survey among Gambian pregnant women in 2000-
01 [36] estimated the prevalence of HIV to be 1.0% (CI:
0.9-2.4%) in Serekunda, an urban settlement approxi-
mately 10 km from Sukuta. Based on this estimate, HIV
+ cases are unlikely to have significantly impacted on
the results of this study, and following ethical guidance
HIV testing was not performed.
Study Design
Demographic, anthropometric and clinical data from
783 mother/child pairs were used to investigate the
association of maternal PM and height and weight in
the first year of life of the offspring. Basic demographic
and socio-economic data, such as, ethnicity, age, and
parity of the mother, education of the parents and, as a
measure for overcrowding, number of persons sleeping
in one bedroom, as well as information on malaria treat-
ment and bednet use were collected in face-to-face
interviews by trained fieldworkers using questionnaires
shortly after birth. Infants were followed up monthly
over a 12-month period for morbidity and anthropo-
metric measurements. At each follow up visit trained
nurses recorded the number of illness episodes during
the previous month reported by the mother or guardian
of the child and administered vaccines according to the
recommended Gambian Expanded Programme of
Immunization schedule. Maternal height and weight
were recorded six months after delivery.
PM status was defined by placental histology. After
birth a placental biopsy was taken and embedded in par-
affin and stained for histological analysis of PM status
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active infection (presence of infected red blood cells in
the intervillous space of the placenta) and past infection
(no parasites, but haemozoin deposition in macro-
phages). Active infection was further subdivided into
acute infections (only parasites and minimal haemozoin
deposition) and chronic infections (parasites and signifi-
cant haemozoin deposition).
Childrens’ weight and length measurements at three,
six and 12 months of age (+/- 15 days) were used to cal-
culate four age/gender-standardized indicators: ‘weight-
for-age’ (wfa), ‘length-for-age’ (lfa), ‘weight-for-length’
(wfl) and ‘body-mass-index-for-age’ (BMIfa) based on
the WHO “Child Growth Standards, 2006” using the
Stata macro ‘igrowup.ado’[38].
Statistical methods
All data were double entered into an Access database
(Microsoft), validated and checked for range and consis-
tency. Prior to investigating if PM is associated with
infant’s size and nutritional status, univariable analyses
were used to assess whether known PM risk factors
(young maternal age, low parity, low socio-economic
status, no bednet use, and seasonality of malaria trans-
mission) [6] were present in this study population. A
logistic regression model was fitted including all risk
f a c t o r sw i t hp - v a l u e sl e s st h a n 0.2 in univariable analy-
sis, which were kept in the model at a significance level
p ≤ 0.05. The final model including parity, PM season
and year, and duration of schooling of the mother was
used to calculate adjusted ORs and corresponding p-
values of being PM+ comparing the individual exposure
groups to a specified baseline group.
The hypothesis that exposure to PM would be asso-
ciated with lower values for anthropometric indicators
was tested at each of the three time points three, six
and 12 months using univariable analyses first. Addi-
tional mother and child characteristics such as maternal
age, height, BMI, parity, duration of schooling, living in
crowded housing conditions as well as gender of the
child, moderate low birth weight of 2,000 g - 2,499 g,
current age of the child, month and year of birth, and
whether the child was born in the ‘hungry’ season (dur-
ing the months with intensive rain fall from July to
October) [39,40] were investigated as risk factors for
reduced indicators. Univariable analyses were conducted
to examine the association of each factor with the four
anthropometric indicators described above at three, six
and 12 months of age.
Cross-sectional times series models using generalized
estimating equations (GEE) to fit the parameters of the
models with exchangeable correlation structure were
then constructed for each anthropometric indicator. The
final models account for multiple weight and length
measurements at three, six and 12 months of age and
confounding factors such as sex, moderate low birth
weight of 2,000 g - 2.499 g, infant’s age, birth month
and year, parity and education (duration of schooling) of
the mother. An interaction term was included for PM
exposure status of the child and parity to investigate if
the association of PM and size of the infant varied
between parity groups. Since the association of PM and
the growth indicators wfa, wfl and BMIfa was not signif-
icantly different for two or three pregnancies, but for
more than four pregnancies compared to the first preg-
nancy, data was split into two groups according to 1-3
and 4 and more pregnancies. Maternal age and living in
crowded housing conditions lacked a significant associa-
tion with z-scores and was therefore not included in the
final models. Mother’s height and BMI were not consid-
ered, since 61% of the data were missing. No difference
was seen for anthropometric measurements taken dur-
ing or after the ‘hungry’ season; thus “hungry season”
was not included in the models. The resulting models
were used to assess the effect of PM exposure on each
anthropometric indicator independent of birth weight.
Whether maternal exposure to PM was associated
with being underweight, wasted or stunted (wfa, wfl or
lfa z-scores<-2, respectively) was investigated using
logistic regression. Odds ratios for the group of wasted
or underweight infants and a second group of stunted
infants were calculated choosing all the remaining well-
nourished infants as the baseline group.
Results
Baseline characteristics of the study population
Available data from 783 mother/child pairs, collected
between January 2002 and July 2005 were analysed. In
each year, with the exception of 2005, a comparable
number of babies were enrolled and genders were
equally distributed with 54.2% (SD 0.5%) being male.
Mean birth weight and length were 3,045 g (SD 449 g)
and 48.5 cm (SD 2.2 cm), respectively. 80 babies (10.3%)
had a birth weight of 2,000 g - 2,499 g. Mean maternal
age was 25.6 years (SD 5.5 years). 74 (9.5%) placentas
were P. falciparum infected; 37/74 (50%) of which were
classified as active infection, which was further sub-
divided into 21/74 (28.4%) acute and 16/74 (21.6%)
chronic infections. The remaining 50% were classified as
past infected. Further maternal and child characteristics
are summarized in Table 1.
Factors associated with PM
The cohort was assessed for known risk factors for PM
[6]. As has been described previously, PM was signifi-
cantly associated with first pregnancy and lower socio-
economic status of the mother. However, in this cohort
initial univariable analysis did not reveal a significant
association of maternal age, BMI, ethnicity, treatment
for malaria and bednet use with PM (Additional file 1).
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quence of PM known to be associated with LBW
[13,17,41-44] was not associated with PM and newborns
in the PM+ group were not significantly lighter than new-
borns in the PM- group (Additional file 2). During the one
year follow up infants in both comparison groups suffered
a similar number of all-cause morbidity episodes.
Lower z-scores for anthropometric indicators for children
born to PM+ mothers independent of LBW
To assess the impact of PM status at birth on growth
development during the first year of life, 1,491 (PM+:
137, PM-: 1354) z-scores for each of four anthropo-
metric indicators (wfa, lfa, BMIfa, and wfl) were ana-
lysed (528 at three months, 510 at six months and 453
at 12 months of age). At all time points mean z-scores
for wfa, lfa, and BMIfa were significantly lower than
zero (mean range across age: wfa: -0.59 to -0.26; lfa:
-0.67 to -0.27; and BMIfa: -0.29 to -0.10), indicating that
Gambian children recruited in the cohort were lighter,
smaller, and had lower values for BMI than children of
the world standard population with same sex and age
characteristics (p < 0.0001). Mean wfl z-scores were sig-
nificantly lower than zero at six months (-0.05, p =
0.038) and 12 months (-0.36, p < 0.0001), but not at
three months (0.06, p = 0.565).
Using univariable analysis comparing children born to
PM+ mothers with those born to PM- mothers, infants
exposed to PM had at least borderline significantly
lower mean z-scores for all four anthropometric indica-
tors at 12 months (Figure 1). Mean differences ranged
from 0.29 z-scores (CI: 0.18; 0.40) to 0.60 z-scores (CI:
0.48; 0.70). The mean differences in z-scores between 12
and three months were not significantly different
between PM+ and PM- groups (wfa: p = 0.738, lfa: p =
0.790, BMIfa: p = 0.9995, and wfl: p = 0.668).
Longitudinal analysis using generalized estimating
equations (GEE) accounting for multiple measurements
for infants at different time points, and for risk factors
for low anthropometric indicators such as parity and
duration of maternal education, moderate low birth
weight (2,000 g - 2.499 g), gender, month and year of
birth, revealed that wfa, BMIfa and wfl z-scores were
significantly associated with maternal PM status for first
to third borns. However, PM exposure had no effect on
lfa z-scores (Table 2).
Figure 1, representing the raw data for each of the
four anthropometric indicators at the three time points
for PM+ and PM- groups, implies that the impact of
PM on anthropometric indicators might be stronger
within the third age group than within the first two
groups. The tests for an interaction of PM and age for
the final GEE models adjusting for confounding factors
such as gender, duration of maternal education and par-
ity, moderate low birth weight, birth month and year of
the infant were not significant. The presented data do
therefore not support the hypothesis of an effect grada-
tion with increasing age.
At the age of three, six and 12 months 20.1%, 9.6%,
and 22.2% of the infants in the PM+ group were either
wasted, underweight or stunted compared to 14.2%,
13.1%, and 17.0% in the PM- group, respectively. The
odds for wasting or being underweight were 2.4 and 3.1
times higher in the PM exposed group at the age of
three and 12 months respectively, but did not reach sig-
nificance (p = 0.095 for both). Infants of the PM+
Table 1 Baseline characteristics of the study population
for 2002-05
Maternal characteristics,
N = 783
No (%)
Age of the mother
Age <20 99 (12.6)
Age 20-24 252 (32.2)
Age 25-29 219 (28.0)
Age ≥30 179 (22.9)
Unknown 34 (4.3)
Number of pregnancies
First 153 (19.5)
Second 173 (22.1)
Third 123 (15.7)
Fourth 100 (12.8)
Fifth 81 (10.4)
Sixth or more 153 (19.5)
Mother’s ethnic group
Mandinka 426 (54.4)
Fula 95 (12.1)
Wolof 87 (11.1)
Jola 78 (10.0)
Serere 37 (4.7)
Serahula 22 (2.8)
Manjago 11 (1.4)
Other 27 (3.5)
Duration of education of the mother
0-4 years 199 (25.4)
5 and more years 403 (51.5)
Unknown 181 (23.1)
Placental malaria
Not infected 709 (90.6)
Acute 21 (2.7)
Chronic 16 (2.0)
Past 37 (4.7)
Baby’s characteristics, N = 783
Year of birth
2002 164 (21.0)
2003 218 (27.8)
2004 277 (35.4)
2005 (January - July) 124 (15.8)
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compared to infants of the PM- group within any age
group.
Steady decline in PM prevalence from January 2002 to
July 2005
As shown in Figure 2, the percentage of mothers with
PM seen at the Sukuta Health Centre decreased signifi-
cantly from 16.5% (27/164) in 2002, to 5.4% (15/277) in
2004 (ptrend < 0.0001). For 2005, data were available for
the non transmission season only (January to July), but
the risk of PM during the non transmission season was
significantly lower in 2004 and 2005 than in 2002 (odds
ratio (OR)2004 0.42, CI (0.18; 0.95), p = 0.038, OR2005
0.08, CI (0.02; 0.37), p-value = 0.001, respectively), with
a highly significant trend (ptrend < 0.001).
Influence of seasonal malaria transmission on PM
prevalence
The majority of PM cases (55/74, 76%) were diagnosed
during the months of October to March (OR 2.85, CI
(1.62; 5.03), p < 0.0001). Mothers delivering during the
malaria transmission period (August to December) were
more likely to be diagnosed with acute PM compared to
mothers delivering during the non-transmission period
from January to July (OR 3.00, CI (1.16; 7.79), p =
0.024; ptrend < 0.011 [AOR 3.00, CI (1.14; 7.94), p* =
0.026, ptrend = 0.014]). By contrast, seasonality of malaria
Figure 1 Anthropometric indicators of infants who were either placental malaria exposed or unexposed during pregnancy.M e d i a n ,
inter quartile range, and range (minimum to maximum value) of four anthropometric indicators weight-for-age, length-for-age, BMI-for-age and
weight-for-length are presented for infants born to placental malaria positive (open boxes) and placental malaria negative mothers (black boxes)
at the age of three, six, and 12 months.
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lence (OR 1.12, CI (0.42; 3.04), p = 0.82). A delayed sea-
sonal effect could be observed for past infections in that
t h e yw e r es i g n i f i c a n t l ym o r el i k e l yt ob ed i a g n o s e di n
the last three months of the malaria transmission season
or thereafter through to March of the following year
(OR 2.97, CI (1.33; 6.66), p < 0.008; [adjusted OR
(AOR) 3.97, CI (1.67; 9.40), adjusted p-value (p*) =
0.005]) (Figure 3).
Discussion
By taking advantage of a cohort study specifically
designed to recruit healthy babies, and subsequent ana-
lysis adjusting for moderate low birth weight, the direct
impact of PM on the infant’s size during the first year
of life independent from LBW-associated effects was
examined. The main aim of this study was to investigate
if babies who were exposed to PM showed a signifi-
cantly different growth pattern during infancy compared
to babies who were not exposed to PM, when the babies
in both groups had a similar weight distribution at birth.
The finding that the birth weights of the PM+ and PM-
groups were not significantly different suggests that we
successfully enrolled babies of similar birth weight dis-
t r i b u t i o ni nb o t hg r o u p s .T h e r e f o r ea n yP Me f f e c t so n
subsequent growth could not be accounted for by a
lower starting birth weight in the PM+ group.
This study shows that first to third born infants of PM
+ mothers were significantly lighter, thinner and had
lower BMIfa z-scores compared to infants of PM-
mothers. The analysis comprised all PM exposed infants
disregarding the histological subgroup of PM. Since
severity of pathological changes within the placenta,
gestational age at infection or duration of infection are
closely associated with PM subgroups, it is likely that
the association of growth development might be differ-
ent within the subgroups past, chronic and active PM.
Unfortunately this study wasn’t sufficiently powered to
enable performance of such subgroup analyses.
PM exposed infants were 2.4 times more likely to be
wasted at the age of three months and 3.1 times more
likely to be underweight at the age of 12 months than
infants born to PM- mothers. Since the described effect
is independent of LBW, this suggests that the overall
Table 2 Association of placental malaria* and anthropo-
metric indicators of infants
Anthropometric
indicator
z-scores difference
[(PM+) - (PM-)]**
CI 95% p-value
Weight-for-age
1-3 pregnancies -0.43 -0.80; -0.07 0.019
≥4 pregnancies 0.02 -0.44; 0.48 0.930
Weight-for-length
1-3 pregnancies -0.47 -0.84; -0.10 0.013
≥4 pregnancies 0.03 -0.44; 0.50 0.903
BMI-for-age
1-3 pregnancies -0.57 -0.84; -0.10 0.012
≥4 pregnancies 0.03 -0.43; 0.50 0.889
Length-for-age
All parities -0.11 -0.37; 0.15 0.405
* Total of past, chronic and active placental malaria (PM)
**Difference in z-scores of PM exposed and unexposed infants (z-score (PM+)
- z-score (PM-))
The table presents the results of the Generalized Estimating Equations models
investigating a possible association of exposure to maternal PM during
pregnancy and anthropometric indicators (weight-for-age (wfa), weight-for-
length (wfl), BMI-for-age (BMIfa) and length-for-age (lfa)) of the infants. 1,488
(PM+:135, PM-:1353) z-scores for each of four anthropometric indicators were
included in the GEE model (1-3 pregnancies: 833 observations (PM+:86, PM-
:747); ≥4 pregnancies: 655 observations (PM+: 49, PM-: 606)). The models
account for multiple weight and length measurements at three, six and 12
months of age and confounding factors such as moderate low birth weight
below (2,000 g - 2,499 g), infant’s age, sex, birth month and year, and
duration of maternal education. Significant interactions between PM infection
and parity were fitted for the first three anthropometric indicators (wfa, wfl,
and BMIfa), but not for lfa.
Figure 2 Decline in placental malaria prevalence during 2002-
2004. The percentage of P. falciparum infected placentas (assessed
by histology) among all women giving birth is shown per annum,
ptrend < 0.0001.
Figure 3 Seasonality of placental malaria. The percentage of
acute (open bars), chronic (dotted bars) and past (black bars)
placental malaria infections is shown over time. From January 2002
till December 2004 21/72 (29.2%) were classified as acute, 16/72
(22.2%) as chronic, and 35/72 (48.6%) as past infection.
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tion, it should be borne in mind that irrespective of PM
status, and despite the exclusion of babies with low
birth weight (≤ 2,000 g), infants recruited in the Sukuta
cohort were significantly lighter, smaller, and had lower
values for BMI than children of the world standard
population. Any additional negative effect on nutritional
status such as that we described here may therefore
become even more relevant for these children.
Overall infants had significantly lower z-scores at 12
months compared to z-scores at three month of age, an
effect which might be explained by a change in feeding
practice and increased mobility of the infant and there-
fore higher exposure to pathogens. A limitation of the
study is that information on gestational age and breast
feeding practices, an important correlate of postnatal
growth, was not collected. However, most mothers
exclusively breast feed for 6 months, and thereafter con-
tinue breast feeding alongside giving solid food past the
age of 1 year. The possibility that the described associa-
tion of PM and infant’s growth development has been
confounded by maternal height and BMI cannot be
excluded. However, among those mothers with available
data for height and BMI (39%), median values were not
significantly different between PM+ and PM- mothers.
The presented findings imply that the increased risk
for poorer weight gain independent of LBW applies to
the first to third born infants of PM+ mothers, but not
for ≥ fourth born children. Gravidity effects have been
described in studies analyzing for the effect of PM on
subsequent susceptibility to malaria in early life [34,45].
These gravidity effects have been attributed to the
higher malaria antigen load and greater degree of pla-
cental inflammation that is thought to occur in the
lower gravidity states, since these woman have lower
anti-chondroitin sulfate A antibody levels and thus less
immunity against PM [45]. However gravidity related
altered susceptibility to malaria itself is unlikely to
account for the delayed growth in the PM exposed
group in this study, since diagnosed malaria was rare in
the 1
st year of life in this population. Therefore other
immunological mechanisms need to be considered.
The inflammatory effects of PM are generally thought to
bias the neonatal immune system towards a Th1 inflam-
matory response [46], and this immune bias could lead to
more severe inflammation in response to other infectious
diseases encountered in the 1
st year of life. Several groups
have proposed that immunological tolerance or regulatory
Tc e l l sm i g h ta l s ob ep r i m e db yP M ,w h i c hm i g h tt h e n
result in altered susceptibility to malaria, and also have a
non-specific immunosuppressive role [47,48]. Indeed, sev-
eral studies have since shown that malaria-specific Tregs
are primed by PM [49-52]. It has also been shown that
non-specific Tregs can be induced by PM, possibly due to
priming of innate responses by malaria antigens via pat-
tern recognition receptors such as the toll like receptors
[52]. Indeed, TLR mutations have been shown to play an
important role in the outcome of pregnancy associated
malaria, and in particular TLR-4 and -9 mutations are
associated with increased risk of low birth weight in term
infants [53]. Altered innate immunity in early life and
increased non-specific Tregs could certainly enhance sus-
ceptibility to other pathogens and antigens and therefore
result in poorer growth development. The number of all
cause morbidity episodes between PM exposed and PM
not exposed infants were not significantly different in the
presented study, although numbers were small and the
severity and duration of illness was not assessed.
One further mechanism as to how PM might influ-
ence early life development independent of birth weight
is its effects on leptin levels. Leptin regulates appetite
and metabolism, and during pregnancy the placenta acts
as an additional source of leptin [54]. PM has been
shown to cause a disruption in the relationship between
leptin and birth weight [55], and although it is not
known whether leptin responsiveness is later restored,
an early lack of leptin responsiveness could certainly
contribute to poor growth in PM+ children. Clearly the
effect of PM on subsequent immunity in early life is a
research an area of great interest, and the precise immu-
nological effects have yet to be fully elucidated.
Several publications report a marked decline of malaria
prevalence over the recent years in sub-Saharan Africa
[56-60]. For The Gambia, a retrospective record based
analysis of malaria incidence spanning from 1999 to 2007
carried out in a region that included the catchment area
of Sukuta Health Centre, observed a marked decline in
the annual number of admissions and deaths attributed
to malaria, particularly since 2003 [61]. Malaria preva-
lence surveys carried out at the end of the transmission
season 2007/8 document unprecedentedly low levels of
malaria in the Gambia and Guinea Bissau [62]. The pre-
sented data on histology-based diagnosis of PM support
this further, documenting a decline in malaria incidence.
While in 2002 the study site could have been classified as
a high transmission region, based on a PM prevalence of
16.5%, PM prevalence decreased markedly to 5.4% in
2004, indicative of low levels of malaria transmission [6].
Since yearly rainfall data for the Gambia, including the
study area Sukuta, do not indicate a significant reduction
in average rainfall during the study period, it is rather
unlikely that changes in rainfall could account for the
observed steep decline in PM prevalence.
A steady increase in bednet coverage in The Gambia
for children <5 years from 42% in 2000 to 63% in 2005
[63] may have contributed to this decline, although in
this study bednet usage was comparable among PM+
and PM- mothers. Intermittent preventative treatment
Walther et al. Malaria Journal 2010, 9:16
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mine (Fansidar®) was introduced at Sukuta HC antenatal
clinic in 2005 and therefore cannot account for the
decline in PM.
Earlier reports suggest a delayed seasonal effect on PM
prevalence in areas of seasonal transmission [13], which
is confirmed by the presented data. Using placental his-
tology it was demonstrated that the vast majority of PM
cases detected in the non transmission season are attri-
butable to past placental infections, reaching a peak in
January to March. As expected, those cases classified as
acute PM closely follow the seasonal transmission pat-
tern, while no significant seasonal variation could be
observed in the incidence of chronic PM.
A previous study in a semi-urban area of The Gambia
showed socio-economic factors, but not education, to be
significantly associated with increased risk for P. falci-
parum infection [64]. In particular, poor and crowded
housing conditions were identified as risk factors. While
crowding was also associated with PM in the presented
dataset, poorer maternal education (duration of school-
ing) was identified as an additional risk factor for PM.
Adequate maternal education may therefore help redu-
cing the burden of PM.
Conclusions
In summary, it was shown that PM exposure during
pregnancy has a negative impact on the infant’sg r o w t h
development for first to third born infants that is inde-
pendent of, but additional to, the well-documented dele-
terious effects of LBW associated with PM
[4,5,20,23,24,65] This suggests that the burden of PM
on the infant’s development may have been underesti-
mated, which points out the paramount importance of
control strategies for malaria in pregnancy. The main
findings of this study, the additional impact of PM on
development of infants and the decline in PM over
time, illustrate the importance of epidemiological data
in designing control measures and determining treat-
ment priorities.
Additional file 1: Risk factors for placental malaria for mothers
delivering at maternity ward of Sukuta Health Centre from January
2002 to July 2005, multivariable analysis for 2002-04. The table
provided represents the results of the statistical analysis assessing the risk
factors for placental malaria (PM).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-2875-9-16-
S1.DOC]
Additional file 2: Association of placental malaria with maternal
anaemia and baby’s characteristics at birth. The table in this file
shows the results of the statistical analysis investigating if maternal and
baby’s outcome characteristics at birth were different between PM+ and
PM- groups.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-2875-9-16-
S2.DOC]
Acknowledgements
The authors thank the study participants, the staff at Sukuta Health Centre
and Sukuta Hospital, in particular Ms Sally Savage. Momadou Jammeh (Royal
Victoria Teaching Hospital, Banjul, The Gambia), Jean-Marie Dangou (Institute
Pasteur, Dakar, Senegal) and Modou Jallow, MRC, The Gambia performed the
placental histology slide preparation and reading. The authors acknowledge
Drs. Arnaud Marchant (Institute for Medical Immunology, Université Libre de
Bruxelles, Charleroi, Belgium), Steve Kaye (Jefferiss Research Trust Laboratory,
Imperial College London, UK) for their contribution to the Sukuta cohort,
and Michael Walther (MRC, The Gambia) for conscientious proof reading of
the manuscript.
This study was funded by the MRC (UK) Laboratories, Fajara, The Gambia.
Author details
1MRC Laboratories, Atlantic Boulevard, Fajara, PO Box 273 Banjul, The
Gambia.
2South African Tuberculosis Vaccine Initiative, Institute of Infectious
Diseases and Molecular Medicine, and School of Child and Adolescent
Health, University of Cape Town, Observatory, South Africa.
3MRC
Epidemiology Resource Centre, University of Southampton, Southampton
General Hospital, Southampton, UK.
4Immunization Department, Health
Protection Agency Centre for Infections, Colindale Avenue, London, UK.
5Adventist Community Services of Alaska, 6100 O’Malley Road, Anchorage,
USA.
6Department of Pediatrics, Bronx-Lebanon Hospital Center, 1650 Grand
Concourse, Bronx, New York, USA.
7Epidemiology and Surveillance Unit,
Centre for Infectious Diseases Control, National Institute for Public Health
and the Environment, Bilthoven, Netherlands.
8MRC Human Immunology
Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital,
Oxford, UK.
Authors’ contributions
DJCM, MVDS, HW, SRJ, and KLF contributed to the conception and design of
the study. DJCM, PW, MSP, OO, ET, MVDS, and KLF contributed to study
implementation and data collection. BW, DJCM, SC performed data analyses
and interpreted the data. BW drafted the manuscript and DJCM, SC, MVDS,
HW, SRJ, and KLF revised it critically. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 11 September 2009
Accepted: 14 January 2010 Published: 14 January 2010
References
1. Walther B, Walther M: What does it take to control malaria?. Ann Trop
Med Parasitol 2007, 101:657-672.
2. WHO: World malaria report 2008. Geneva, Switzerland: WHO Press 2008.
3. Korenromp EL: Malaria incidence estimates at country level for the year
2004 - proposed estimates and draft report for the roll back malaria
monitoring and evaluation reference group merg task force on malaria
morbidity. Geneva, Roll Back Malaria, World Health Organization 2004.
4. Steketee RW, Nahlen BL, Parise ME, Menendez C: The burden of malaria in
pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64:28-35.
5. Guyatt HL, Snow RW: Impact of malaria during pregnancy on low birth
weight in sub-saharan africa. Clin Microbiol Rev 2004, 17:760-769.
6. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B,
Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet
Infect Dis 2007, 7:93-104.
7. Kasumba IN, Nalunkuma AJ, Mujuzi G, Kitaka FS, Byaruhanga R, Okong P,
Egwang TG: Low birthweight associated with maternal anaemia and
plasmodium falciparum infection during pregnancy, in a peri-urban/
urban area of low endemicity in uganda. Ann Trop Med Parasitol 2000,
94:7-13.
8. Brabin B, Piper C: Anaemia- and malaria-attributable low birthweight in
two populations in papua new guinea. Ann Hum Biol 1997, 24:547-555.
9. Duffy PE, Fried M: Malaria during pregnancy: Parasites, antibodies and
chondroitin sulphate a. Biochem Soc Trans 1999, 27:478-482.
10. Beeson JG, Amin N, Kanjala M, Rogerson SJ: Selective accumulation of
mature asexual stages of plasmodium falciparum-infected erythrocytes
in the placenta. Infect Immun 2002, 70:5412-5415.
Walther et al. Malaria Journal 2010, 9:16
http://www.malariajournal.com/content/9/1/16
Page 8 of 1011. Fried M, Duffy PE: Adherence of plasmodium falciparum to chondroitin
sulfate a in the human placenta. Science 1996, 272:1502-1504.
12. Fried M, Domingo GJ, Gowda CD, Mutabingwa TK, Duffy PE: Plasmodium
falciparum: Chondroitin sulfate a is the major receptor for adhesion of
parasitized erythrocytes in the placenta. Exp Parasitol 2006, 113:36-42.
13. Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH, McGready R,
Fletcher KA, Owens S, D’Alessandro U, Nosten F, Fischer PR, Ordi J: The sick
placenta-the role of malaria. Placenta 2004, 25:359-378.
14. Moormann AM, Sullivan AD, Rochford RA, Chensue SW, Bock PJ, Nyirenda T,
Meshnick SR: Malaria and pregnancy: Placental cytokine expression and
its relationship to intrauterine growth retardation. J Infect Dis 1999,
180:1987-1993.
15. Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, Font F,
Alonso PL: The impact of placental malaria on gestational age and birth
weight. J Infect Dis 2000, 181:1740-1745.
16. Suguitan AL Jr, Cadigan TJ, Nguyen TA, Zhou A, Leke RJ, Metenou S,
Thuita L, Megnekou R, Fogako J, Leke RG, Taylor DW: Malaria-associated
cytokine changes in the placenta of women with pre-term deliveries in
yaounde, cameroon. Am J Trop Med Hyg 2003, 69:574-581.
17. Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, Marsh K:
Malaria in pregnancy: Adverse effects on haemoglobin levels and
birthweight in primigravidae and multigravidae. Trop Med Int Health
2001, 6:770-778.
18. Rogerson SJ, Pollina E, Getachew A, Tadesse E, Lema VM, Molyneux ME:
Placental monocyte infiltrates in response to plasmodium falciparum
malaria infection and their association with adverse pregnancy
outcomes. Am J Trop Med Hyg 2003, 68:115-119.
19. Rogerson SJ: Sequestration: Causes and consequences. Redox Rep 2003,
8:295-299.
20. Sarr D, Marrama L, Gaye A, Dangou JM, Niang M, Mercereau-Puijalon O,
Lehesran JY, Jambou R: High prevalence of placental malaria and low
birth weight in sahelian periurban area. Am J Trop Med Hyg 2006, 75:171-
177.
21. Kramer MS: Determinants of low birth weight: Methodological
assessment and meta-analysis. Bull World Health Organ 1987, 65:663-737.
22. McCormick MC: The contribution of low birth weight to infant mortality
and childhood morbidity. N Engl J Med 1985, 312:82-90.
23. Guyatt HL, Snow RW: Malaria in pregnancy as an indirect cause of infant
mortality in sub-saharan africa. Trans R Soc Trop Med Hyg 2001, 95:569-
576.
24. Greenwood AM, Armstrong JR, Byass P, Snow RW, Greenwood BM: Malaria
chemoprophylaxis, birth weight and child survival. Trans R Soc Trop Med
Hyg 1992, 86:483-485.
25. Luxemburger C, McGready R, Kham A, Morison L, Cho T,
Chongsuphajaisiddhi T, White NJ, Nosten F: Effects of malaria during
pregnancy on infant mortality in an area of low malaria transmission.
Am J Epidemiol 2001, 154:459-465.
26. Murphy SC, Breman JG: Gaps in the childhood malaria burden in africa:
Cerebral malaria, neurological sequelae, anemia, respiratory distress,
hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001,
64:57-67.
27. Garner P, Kramer MS, Chalmers I: Might efforts to increase birthweight in
undernourished women do more harm than good?. Lancet 1992,
340:1021-1023.
28. van Geertruyden JP, Thomas F, Erhart A, D’Alessandro U: The contribution
of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004,
71:35-40.
29. Sande van der MA, Kaye S, Miles DJ, Waight P, Jeffries DJ, Ojuola OO,
Palmero M, Pinder M, Ismaili J, Flanagan KL, Aveika AA, Zaman A, Rowland-
Jones S, McConkey SJ, Whittle HC, Marchant A: Risk factors for and clinical
outcome of congenital cytomegalovirus infection in a peri-urban west-
african birth cohort. PLoS ONE 2007, 2:e492.
30. Kalanda BF, van Buuren S, Verhoeff FH, Brabin BJ: Catch-up growth in
malawian babies, a longitudinal study of normal and low birthweight
babies born in a malarious endemic area. Early Hum Dev 2005, 81:841-
850.
31. Barker DJP: Fetal and infant origins of disease London: BMJ Books 1992.
32. Ashworth A: Effects of intrauterine growth retardation on mortality and
morbidity in infants and young children. Eur J Clin Nutr 1998, 52(1):S34-
41, discussion S41-32.
33. Victora CG, Smith PG, Vaughan JP, Nobre LC, Lombardi C, Teixeira AM,
Fuchs SM, Moreira LB, Gigante LP, Barros FC: Influence of birth weight on
mortality from infectious diseases: A case-control study. Pediatrics 1988,
81:807-811.
34. Schwarz NG, Adegnika AA, Breitling LP, Gabor J, Agnandji ST, Newman RD,
Lell B, Issifou S, Yazdanbakhsh M, Luty AJ, Kremsner PG, Grobusch MP:
Placental malaria increases malaria risk in the first 30 months of life. Clin
Infect Dis 2008, 47:1017-1025.
35. Duijts L, Bakker-Jonges LE, Labout JA, Jaddoe VW, Hofman A, Steegers EA,
van Dongen JJ, Hooijkaas H, Moll HA: Fetal growth influences lymphocyte
subset counts at birth: The generation r study. Neonatology 2008, 95:149-
156.
36. Schim van der Loeff MF, Sarge-Njie R, Ceesay S, Awasana AA, Jaye P,
Sam O, Jaiteh KO, Cubitt D, Milligan P, Whittle HC: Regional differences in
hiv trends in the gambia: Results from sentinel surveillance among
pregnant women. Aids 2003, 17:1841-1846.
37. Ismail MR, Ordi J, Menendez C, Ventura PJ, Aponte JJ, Kahigwa E, Hirt R,
Cardesa A, Alonso PL: Placental pathology in malaria: A histological,
immunohistochemical, and quantitative study. Hum Pathol 2000, 31:85-
93.
38. WHO: Who child growth standards: Length/height-for-age, weight-for-
age, weight-for-length, weight-for-height and bodymass index-for-age:
Methods and development. World Health Organization, Geneva 2006.
39. Moore SE, Collinson AC, Tamba N’Gom P, Aspinall R, Prentice AM: Early
immunological development and mortality from infectious disease in
later life. Proc Nutr Soc 2006, 65:311-318.
40. Ceesay SM, Prentice AM, Cole TJ, Foord F, Weaver LT, Poskitt EM,
Whitehead RG: Effects on birth weight and perinatal mortality of
maternal dietary supplements in rural gambia: 5 year randomised
controlled trial. Bmj 1997, 315:786-790.
41. Brabin BJ, Hakimi M, Pelletier D: An analysis of anemia and pregnancy-
related maternal mortality. J Nutr 2001, 131:604S-614S, discussion 614S-
615S.
42. Hirve SS, Ganatra BR: Determinants of low birth weight: A community
based prospective cohort study. Indian Pediatr 1994, 31:1221-1225.
43. von Tempelhoff GF, Heilmann L, Rudig L, Pollow K, Hommel G, Koscielny J:
Mean maternal second-trimester hemoglobin concentration and
outcome of pregnancy: A population-based study. Clin Appl Thromb
Hemost 2008, 14:19-28.
44. Shulman CE, Dorman EK, Bulmer JN: Malaria as a cause of severe anaemia
in pregnancy. Lancet 2002, 360:494.
45. Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, Fried M, Duffy PE:
Maternal malaria and gravidity interact to modify infant susceptibility to
malaria. PLoS Med 2005, 2:e407.
46. Broen K, Brustoski K, Engelmann I, Luty AJ: Placental plasmodium
falciparum infection: Causes and consequences of in utero sensitization
to parasite antigens. Mol Biochem Parasitol 2007, 151:1-8.
47. Le Hesran JY, Cot M, Personne P, Fievet N, Dubois B, Beyeme M, Boudin C,
Deloron P: Maternal placental infection with plasmodium falciparum and
malaria morbidity during the first 2 years of life. Am J Epidemiol 1997,
146:826-831.
48. Cot M, Le Hesran JY, Staalsoe T, Fievet N, Hviid L, Deloron P: Maternally
transmitted antibodies to pregnancy-associated variant antigens on the
surface of erythrocytes infected with plasmodium falciparum: Relation
to child susceptibility to malaria. Am J Epidemiol 2003, 157:203-209.
49. Brustoski K, Moller U, Kramer M, Hartgers FC, Kremsner PG, Krzych U,
Luty AJ: Reduced cord blood immune effector-cell responsiveness
mediated by cd4+ cells induced in utero as a consequence of placental
plasmodium falciparum infection. J Infect Dis 2006, 193:146-154.
50. Malhotra I, Dent A, Mungai P, Wamachi A, Ouma JH, Narum DL, Muchiri E,
Tisch DJ, King CL: Can prenatal malaria exposure produce an immune
tolerant phenotype? A prospective birth cohort study in kenya. PLoS
Med 2009, 6:e1000116.
51. Bisseye C, Sande van der M, Morgan WD, Holder AA, Pinder M, Ismaili J:
Plasmodium falciparum infection of the placenta impacts on the t
helper type 1 (th1)/th2 balance of neonatal t cells through cd4(+)cd25
(+) forkhead box p3(+) regulatory t cells and interleukin-10. Clin Exp
Immunol 2009, 158:287-293.
52. Flanagan K, Halliday A, Burl S, Landgraf K, Jagne YJ, Noho-Konteh F,
Townend J, Miles DJC, Sande van der M, Whittle H, Rowland-Jones S: The
Walther et al. Malaria Journal 2010, 9:16
http://www.malariajournal.com/content/9/1/16
Page 9 of 10effect of placental malaria infection on cord blood and maternal
immunoregulatory responses at birth. Eur J Immunol .
53. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR,
Otchwemah RN, Dietz E, Ehrhardt S, Schroder NW, Bienzle U, Schumann RR:
Toll-like receptor (tlr) polymorphisms in african children: Common tlr-4
variants predispose to severe malaria. Proc Natl Acad Sci USA 2006,
103:177-182.
54. Linnemann K, Malek A, Schneider H, Fusch C: Physiological and
pathological regulation of feto/placento/maternal leptin expression.
Biochem Soc Trans 2001, 29:86-90.
55. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE: Fetal responses
during placental malaria modify the risk of low birth weight. Infect
Immun 2008, 76:1527-1534.
56. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini U,
Ogbamariam A, Kosia A, Gebremichael A, Gunawardena D, Ghebrat Y,
Okbaldet Y: A steep decline of malaria morbidity and mortality trends in
eritrea between 2000 and 2004: The effect of combination of control
methods. Malar J 2006, 5(33).
57. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, Al-
Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S,
Montgomery SM, Kaneko A, Bjorkman A: Impact of artemisinin-based
combination therapy and insecticide-treated nets on malaria burden in
zanzibar. PLoS Med 2007, 4:e309.
58. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K,
Snow RW: The decline in paediatric malaria admissions on the coast of
kenya. Malar J 2007, 6:151.
59. Rodrigues A, Schellenberg JA, Kofoed PE, Aaby P, Greenwood B: Changing
pattern of malaria in bissau, guinea bissau. Trop Med Int Health 2008,
13:410-417.
60. O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW,
Newton CR, Marsh K: Effect of a fall in malaria transmission on morbidity
and mortality in kilifi, kenya. Lancet 2008, 372:1555-1562.
61. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ,
Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T,
Bojang KA, Whittle HC, Greenwood BM, Conway DJ: Changes in malaria
indices between 1999 and 2007 in the gambia: A retrospective analysis.
Lancet 2008, 372:1545-1554.
62. Satoguina J, Walther B, Drakeley C, Nwakanma D, Oriero EC, Correa S,
Corran P, Conway DJ, Walther M: Comparison of surveillance methods
applied to a situation of low malaria prevalence at rural sites in the
gambia and guinea bissau. Malar J 2009, 8:274.
63. (GBoS) GBoS: The gambia multiple indicator cluster survey 2005/2006,
report, banjul. 2007.
64. Koram KA, Bennett S, Adiamah JH, Greenwood BM: Socio-economic risk
factors for malaria in a peri-urban area of the gambia. Trans R Soc Trop
Med Hyg 1995, 89:146-150.
65. Kassam SN, Nesbitt S, Hunt LP, Oster N, Soothill P, Sergi C: Pregnancy
outcomes in women with or without placental malaria infection. Int J
Gynaecol Obstet 2006, 93:225-232.
doi:10.1186/1475-2875-9-16
Cite this article as: Walther et al.: Placental Malaria is associated with
reduced early life weight development of affected children
independent of low birth weight. Malaria Journal 2010 9:16.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Walther et al. Malaria Journal 2010, 9:16
http://www.malariajournal.com/content/9/1/16
Page 10 of 10